A golden retriever and a tabby cat in a veterinary clinic
Vet-Tech Innovation

Early pet cancer detection, made simple.

UriBxcan tell.

  Revolutionary non-invasive cancer screening that decodes the silent signals of your pet's health. Precision oncology at Veterinaries' fingertips.

Spot the cancer at hi, not at bye.

Cancer is a leading cause of death in dogs and cats. Most pet owners would prefer to know it ahead and do something about it; Now your veterinary clinic can offer it for your companion friend.

Built for your veterinary practice, UriBx reads tumour biomarkers directly from a urine sample whatever the cancer type or location.

Pan-cancer screening from a single urine specimen — no need to know the tumour type in advance.

Often detects cancer signals before clinical signs appear, enabling earlier intervention.

Can be easily added to routine wellness and preventative care profiles for both dogs and cats.

Validated in independent clinical studies and backed by expert oncology guidance.

Early. Accurate. Proven.

Independent clinical trials confirm 99% accuracy in distinguishing cancer-positive from cancer-negative samples — a level of performance that exceeds any current standards in pets early cancer diagnosis screening.

99%
clinical accuracy

*Based on manufacturer internal laboratory validation data and partner veterinary clinical trials.

POC
chair-side result
Both
DOGS
AND CATS
All
Cancer Types

Performance validated across breeds, ages and tumour types in peer-reviewed studies.

CLINICAL VALIDATION

Independent, biopsy-confirmed results

99%
Sensitivity

cancer cases flagged

*Based on manufacturer internal laboratory validation data and partner veterinary clinical trials.

99%
Specificity

healthy animals cleared

*Based on manufacturer internal laboratory validation data and partner veterinary clinical trials.

THE COHORT — 720 cats & dogs

180 cats

540 dogs

all sizes multi breeds

HOW IT WAS RUN

in the acreditted veterinary clinics and animal hospitals tumour flag validated against biopsy / histopathology (in gold standards).

 Clinical trials Conducted under the approval and oversight of the Clinical Research Ethics Committee, Ege University Faculty of Veterinary Medicine (a top 5% globally ranked state research institution).

Rapid point-of-care (POC) results within minutes.

No waiting days for a lab. UriBx delivers a clear yes/no answer chair-side, within minutes — so you can act on the same visit.

Same-visit answers mean treatment can start weeks earlier — when outcomes are best.

  • Sample to result in a single appointment — no courier, no lab queue.
  • Runs chair-side on standard clinic equipment, with no specialist training.
  • One clear yes/no readout you can discuss with the owner before they leave.
Learn how easy it is in-clinic →

Easily performed in-clinic

No specialised equipment or lengthy training required. URIBX OncoCheck fits into your routine workflow so you can run it chair-side.

Simple workflow

Collect a urine sample, run the test, and get a clear yes/no result within minutes.

Minimal training

Your team can learn the protocol quickly — no lab specialists or complex infrastructure needed.

Same-visit decisions

Act on results during the appointment, not days later, so owners leave with answers.

The technology behindURIBX

A "lab on a chip" liquid biopsy that combines proprietary One-X polymer chemistry with AI Software to read cancer biomarkers directly from urine.

One-X Polymer

A proprietary polymer that selectively binds tumour-derived metabolites in the urine matrix and converts the binding into a precise absorbance signal.

AI Software

On-device AI Software interprets the optical signal and returns a quantitative, clinically validated cancer present / not present result.

Multidisciplinary R&D

Ten years of research combining chemistry, biotechnology, materials science and physics into a single chair-side workflow.

We added deeper insights to your routine and preventative care offerings.

URIBX OncoCheck integrates seamlessly into routine wellness profiles for dogs and cats. Combined with URIBX Preventative Care, you get tools to spot trends across visits, interpret patient results, and tailor recommendations to every individual patient.

Ask UriBx

See cancer before it shows itself.

Quarterly screening is advised for every cat or dog at higher risk of cancer — from older pets to those showing vague, hard-to-place symptoms. Since the test isn't tied to any single tumour type, it performs identically across every species and breed.

Cats from any 5 years of age
Dogs of any age
Sudden, unexplained weight loss
Ongoing low energy or fatigue
Unusual results on routine bloodwork
Risk check before anaesthesia

Support

Resources

Explore everything you need to use URIBX OncoCheck — white paper, testing algorithm and FAQs all in one place.

Medical consultants

One-to-one access to our team of medical experts and board-certified veterinary specialists, whenever you need a second opinion.

Cancer-free

The best result a vet visit can bring.

Every negative result is a moment of relief — for the family, for the clinic, and most of all for the patient. URIBX  is built to deliver more of these moments.

A happy dog and cat after receiving a cancer-free result

Complete this form to have an UriBx representative contact you.

URIBX considers proper processing of personal data to be highly important. See our Privacy Policy.